Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.

Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
复制标题

DOI:
10.1038/sj.bjc.6605122
复制
发表时间:
2009-07-07
影响因子:
8.8
通讯作者:
--
中科院分区:
医学1区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

我们最近通过微阵列研究确定并验证了UBE2C RNA作为252例淋巴结阳性(N+)乳腺癌的预后标志物。本研究的目的是通过免疫组化(IHC)验证UBE2C蛋白作为N+乳腺癌的预后标志物。为此,使用了92块石蜡包埋块。评估UBE2C IHC值对无转移生存期(MFS)和总生存期(OS)的影响,并与Ki-67和诺丁汉预后指数(NPI)表现进行比较。根据基因组数据,UBE2C IHC对MFS和OS均有显著影响(风险比分别为6.79 - P=0.002和7.14 - P=0.009)。赤池信息标准证实UBE2C IHC的预后能力强于Ki-67(且与NPI接近)。此外,NPI的多变量分析显示,与Ki-67 IHC相反,UBE2C IHC仍然是MFS(校正P=0.02)和OS(校正P=0.04)的独立因素。我们证实IHC检测的UBE2C蛋白可以作为N+乳腺癌的预后标志物。UBE2C作为蛋白酶体活性标记物的潜在预测价值需要进一步研究。
We recently identified and validated UBE2C RNA as a prognostic marker in 252 node-positive (N+) breast cancers by means of a microarray study. The aim of this study was to validate UBE2C protein as a prognostic marker in N+ breast cancer by immunohistochemistry (IHC). To this end, 92 paraffin-embedded blocks were used. The impact of UBE2C IHC value on metastasis-free survival (MFS) and overall survival (OS) was evaluated and compared with Ki-67 and Nottingham prognostic index (NPI) performances. In accordance with genomic data, UBE2C IHC had a significant impact both on MFS and OS (hazard ratio=6.79 – P=0.002; hazard ratio=7.14 – P=0.009, respectively). Akaike information criterion proved that the prognostic power of UBE2C IHC was stronger than that of Ki-67 (and close to that of NPI). Furthermore, multivariate analyses with NPI showed that, contrary to Ki-67 IHC, UBE2C IHC remained an independent factor, both for MFS (adjusted P=0.02) and OS (adjusted P=0.04). We confirmed that UBE2C protein measured by IHC could be used as a prognostic marker in N+ breast cancer. The potential predictive interest of UBE2C as a marker of proteasome activity needs further investigations.
DOI: 10.1016/s0002-9440(10)63556-0
发表时间: 2003-11-01
影响因子: 6
作者:
Kauraniemi, P;Kuukasjärvi, T;Kallioniemi, A
通讯作者: Kallioniemi, A
DOI: 10.1186/bcr2124
发表时间: 2008
期刊: Breast cancer research : BCR
影响因子: --
作者:
Wirapati P;Sotiriou C;Kunkel S;Farmer P;Pradervand S;Haibe-Kains B;Desmedt C;Ignatiadis M;Sengstag T;Schütz F;Goldstein DR;Piccart M;Delorenzi M
通讯作者: Delorenzi M
DOI: 10.1007/s10549-007-9673-x
发表时间: 2008-06-01
影响因子: 3.8
作者:
Campone, Mario;Campion, Loic;Jezequel, Pascal
通讯作者: Jezequel, Pascal
DOI: 10.1007/s10549-006-9393-7
发表时间: 2007-07-01
影响因子: 3.8
作者:
Deng, Shishan;Zhou, Hongying;Yang, Huijun
通讯作者: Yang, Huijun
DOI: 10.1038/sj.onc.1207861
发表时间: 2004-08-26
期刊: ONCOGENE
影响因子: 8
作者:
Wagner, KW;Sapinoso, LM;Hampton, GM
通讯作者: Hampton, GM